NORGES BANK - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 3 filers reported holding SEATTLE GENETICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORGES BANK ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$212,467,000
+49.3%
1,085,734
+29.6%
0.06%
+36.6%
Q2 2020$142,354,000
+29.4%
837,768
-12.2%
0.04%
+5.1%
Q1 2020$110,050,000
+6.5%
953,803
+5.5%
0.04%
+34.5%
Q4 2019$103,301,000
+33.8%
904,0830.0%0.03%
+20.8%
Q3 2019$77,209,000
+41.0%
904,083
+14.3%
0.02%
+41.2%
Q2 2019$54,765,000
-5.5%
791,2890.0%0.02%
-10.5%
Q1 2019$57,954,000
+31.5%
791,289
+1.7%
0.02%
+18.8%
Q4 2018$44,082,000
-30.0%
778,011
-4.7%
0.02%
-20.0%
Q3 2018$62,948,000
+19.7%
816,232
+3.1%
0.02%
+11.1%
Q2 2018$52,585,000
+1.3%
792,049
-20.2%
0.02%
-5.3%
Q1 2018$51,920,000
-4.0%
991,984
-1.9%
0.02%0.0%
Q4 2017$54,075,000
-10.0%
1,010,749
-8.5%
0.02%
-17.4%
Q3 2017$60,092,000
+22.0%
1,104,415
+16.0%
0.02%
+15.0%
Q2 2017$49,267,000
-10.1%
952,200
+9.2%
0.02%
-9.1%
Q1 2017$54,830,000
-4.6%
872,255
-19.9%
0.02%
-12.0%
Q4 2016$57,470,000
+31.1%
1,089,077
+28.2%
0.02%
+19.0%
Q3 2016$43,831,000
+19.1%
849,671
-6.7%
0.02%
+23.5%
Q2 2016$36,794,000
+25.0%
910,520
+8.6%
0.02%
+21.4%
Q1 2016$29,433,000
-25.7%
838,784
-5.0%
0.01%
-30.0%
Q4 2015$39,635,000
+16.4%
883,1240.0%0.02%
+11.1%
Q3 2015$34,053,000
-24.4%
883,124
-5.1%
0.02%
-21.7%
Q2 2015$45,062,000
+36.9%
931,0410.0%0.02%
+43.8%
Q1 2015$32,912,000
+8.0%
931,041
-1.9%
0.02%
+6.7%
Q4 2014$30,480,000
+1.6%
948,636
+17.6%
0.02%
-6.2%
Q3 2014$30,003,000
-51.4%
806,985
-50.0%
0.02%
-5.9%
Q2 2014$61,734,000
+73.4%
1,613,970
+106.6%
0.02%
-15.0%
Q1 2014$35,593,000
+14.2%
781,2380.0%0.02%
+11.1%
Q4 2013$31,163,000
-3.0%
781,238
+6.6%
0.02%
-5.3%
Q3 2013$32,134,000
+78.9%
733,167
+28.4%
0.02%
+72.7%
Q2 2013$17,959,000
+30.0%
570,838
+46.8%
0.01%
+22.2%
Q1 2013$13,810,000
+31.8%
388,9130.0%0.01%
+28.6%
Q3 2012$10,481,000
-5.6%
388,913
-8.3%
0.01%
-22.2%
Q2 2012$11,100,000424,3110.01%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,365,840,00020.68%
Lagoda Investment Management, L.P. 398,529$20,620,0007.88%
Matrix Capital Management Company, LP 2,118,000$109,585,0003.72%
Ghost Tree Capital, LLC 300,000$15,522,0003.23%
Sio Capital Management, LLC 100,000$5,174,0002.46%
GREAT POINT PARTNERS LLC 249,500$12,909,0002.31%
Redmile Group, LLC 665,139$34,414,0002.10%
Eventide Asset Management 525,000$27,164,0001.69%
Opus Point Partners Management, LLC 35,093$1,816,0001.66%
Boxer Capital, LLC 125,000$6,468,0001.54%
View complete list of SEATTLE GENETICS INC shareholders